Crizotinib, sold under the brand name Xalkori among others, is an anti-cancer medication used for the treatment of non-small cell lung carcinoma (NSCLC) and relapsed anaplastic large cell lymphoma (Passerini et al., 2014, JNCI). It inhibits the action of the EML4-ALK fusion protein as an inhibitor (Lei et al., 2022, Oncol Lett).
What is Crizotinib?
Posted
in
by
Tags:
Leave a Reply
You must be logged in to post a comment.